Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
J.H. Whitney Equity Partners VII, LLC, a major shareholder in Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), recently sold 750,000 shares of the company’s common stock. The transaction, which took place on June 10, 2025, was executed at a price of $5.20 per share, amounting to a total sale value of $3.9 million. The sale comes as AVAH stock has demonstrated remarkable strength, posting a 106% return over the past year, with the company now valued at approximately $1.05 billion.
Following this transaction, J.H. Whitney continues to hold a significant position in Aveanna Healthcare. The shares are indirectly owned through various entities, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC. Specifically, 28,890,756 shares are held by J.H. Whitney VII, L.P., 15,588,582 shares by PSA Healthcare Investment Holding LLC, and 1,443,143 shares by PSA Iliad Holdings LLC.
This sale marks a notable transaction for Aveanna Healthcare, which is a key player in the healthcare sector, particularly in providing home healthcare services. Investors may keep an eye on any potential impacts this transaction could have on the company’s stock performance.
In other recent news, Aveanna Healthcare Holdings Inc. reported impressive financial results for the first quarter of 2025. The company achieved earnings per share of $0.10, which was a significant improvement over the forecasted loss of $0.0014. Aveanna’s revenue reached $559 million, exceeding analyst expectations of $513.7 million. The company has also projected strong growth for the year, with revenue expected to surpass $2.15 billion. Additionally, Aveanna announced the results of its 2025 Annual Meeting of Stockholders, where stockholders approved the election of directors and the ratification of Ernst & Young LLP as the company’s independent auditor. The company is also focused on strategic growth initiatives, such as its recently announced acquisition of ThriveSkilled Pediatrics, which is expected to close soon. This acquisition is part of Aveanna’s strategy to enhance its preferred payer and government affairs efforts. Lastly, the company continues to face challenges in the labor market and regulatory changes but remains optimistic about its future performance, supported by its partnerships and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.